On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Five years ago panicked postmenopausal women threw away their hormone pills after the federal government revealed that the drugs raised the risk of breast cancer and coronary disease. In 2006 only six million U.S. women got hormone prescriptions, a dramatic drop from 16 million in 2001. It seemed like the end for hormone therapy, especially for the previously fashionable notion that hormones protected older women from cardiovascular disease and other ills caused by aging.
But papers published this year, written by researchers who delivered the original warning, show that taking hormones soon after menopause—within about 10 years—is safe for most women. The data even suggest that hormone therapy for less than 10 years may improve some women’s health more than doing nothing.
Subscribe to Support Independent Journalism
Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.
When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.
Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber
